-
Based on the current information provided, the cause of bleeding cannot be determined.A review of the site's system logs for the reported procedure date was conducted by an isi senior failure analysis engineer.Investigation revealed there were no related system errors to have occurred during the procedure that were relevant to the reported event.A review of the event was conducted by an isi medical safety officer and the following additional information was provided: a 81-year-old patient underwent an ion biopsy of a right upper lobe nodule.Bleeding was noted after obtaining a cryoprobe biopsy.Lavage was performed with 700ml of bloody return.A balloon blocker was reportedly not available in the hospital.2 units of prbc were transfused and the patient was transferred to the icu.A few hours later the patient was successfully extubated.The patient was discharged home after 3 days on 2 lpm of oxygen.Of note the patient was on blood thinners which were reportedly held for the procedure.Attempts at obtaining further information have been unsuccessful.There was no malfunction of the ion system, instruments or accessories.Based on the available data the reported event was procedure related and not device related.Bronchoscopy is a minimally invasive procedure with a low risk profile.A retrospective study of 20,986 bronchoscopies reported 21 episodes of hemoptysis of > 50 ml (0.38%) and 19 episodes < 50 ml (0.34%).A prospective multicenter international study of 1,215 navigational bronchoscopy cases reported a bleeding rate of 2.5% overall and a ctcae grade 2 or greater bleeding rate of 1.5%.A single center retrospective review of 19,017 bronchoscopic biopsies reported a severe bleeding rate of 0.79% with a higher rate in more central lesions.A recent meta-analysis of navigational bronchoscopy in 10,381 patients reported an overall adverse event rate of 5.6% with 1 death.Bleeding of any severity was reported in 2.1% of all cases.Folch ee, pritchett ma, nead ma, et al.Electromagnetic navigation bronchoscopy for peripheral pulmonary lesions: one-year results of the prospective, multicenter navigate study.Journal of thoracic oncology.2019.Facciolongo n, patelli m, gasparini s, et al.Incidence of complications in bronchoscopy.Multicentre prospective study of 20,986 bronchoscopies.Monaldi archives for chest disease.2009.Kops sep, heus p, korevaar da, et al.Diagnostic yield and safety of navigation bronchoscopy: a systematic review and meta-analysis.Lung cancer.2023. It was reported that during an ion endoluminal lung biopsy procedure, the patient experienced bleeding which required medical intervention and hospitalization.The patient was known to be on blood thinners, but they were appropriately stopped before the procedure.The target nodule was less than 1 centimeter in size and located in the right upper lobe close to a blood vessel.During biopsy workflow, the physician used a cryoprobe on the target lesion.When the probe was retracted, bleeding was noted in the endotracheal tube.An emergent endobronchial lavage was performed, and the estimated blood loss was around 700 milliliters (ml).A balloon blocker was not used as there was not one available in the hospital.The specific interventions required to control the bleeding were not reported, but there was a procedure delay of 1 hour.The patient received 2 units of blood and was transferred to the intensive care unit (icu).A few hours later, the patient was extubated.The patient stayed in the hospital for 3 days and repeated chest x-rays showed improved condition.Upon discharge, the patient was prescribed 2 liters per minute of oxygen for home use.The physician reported that the bleeding was not directly caused by the ion procedure.They mentioned that this was a high-risk procedure and bleeding would have likely occurred regardless of the modality used.There was no device malfunction associated with the bleeding event. ION SYSTEM CART K182188 DA VINCI INSTRUMENTS AND ACCESSORIES510(k) | DeNovo | | Adverse Events | Recalls | PMA | HDE | Classification | Standards CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
INTUITIVE SURGICAL, INC ION; SYSTEM CART Back to Search Results Model Number 380748-60 Device ProblemAdverse Event Without Identified Device or Use Problem (2993) Patient ProblemHemorrhage/Bleeding (1888) Event Date10/02/2024 Event TypeInjury Manufacturer Narrative Event Description Search Alerts/Recalls New Search|Submit an Adverse Event Report Brand Name Type of Device Manufacturer (Section D) INTUITIVE SURGICAL, INC 3410 central expressway santa clara CA 95051 Manufacturer (Section G) INTUITIVE SURGICAL, INC 3410 central expressway santa clara CA 95051 Manufacturer Contact izabel nielson 3410 central expressway santa clara, CA95051 4085232100 MDR Report Key 20567349 MDR Text Key 355423153 Report Number 2955842-2024-21368 Device Sequence Number 1 Product Code EOQ UDI-Device Identifier 00886874116234 UDI-Public (01)00886874116234 Combination Product (y/n) N Reporter Country Code US PMA/PMN Number Number of Events Reported 1 Summary Report (Y/N) N Report Source Manufacturer Source Type Other,Health Professional Reporter Occupation Physician Remedial Action Other Type of Report Initial Report Date 10/02/2024 1 Device was Involved in the Event 1 Patient was Involved in the Event Is this an Adverse Event Report? Yes Is this a Product Problem Report? No Device Operator Health Professional Device Model Number 380748-60 Device Catalogue Number 380748 Device Lot Number N/A Was Device Available for Evaluation? No Is the Reporter a Health Professional? Yes Initial Date Manufacturer Received 10/02/2024 Initial Date FDA Received 10/30/2024 Was Device Evaluated by Manufacturer? No Date Device Manufactured 11/07/2021 Is the Device Single Use? No Is This a Reprocessed and Reused Single-Use Device? No Type of Device Usage Reuse Removal/Correction Number N/A Patient Sequence Number 1 Treatment Patient Outcome(s) Required Intervention; Hospitalization; Patient Age 81 YR Patient Sex Female Patient Weight 60 KG Patient Ethnicity Non Hispanic Patient Race White
-